SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from UTG INC (UTGN) (CIK 0000832480) (UTGN) — Jun 21, 2005

UTG INC (UTGN) (CIK 0000832480)
Date: June 21, 2005 · CIK: 0000832480 · Accession: 0000832480-05-000008

AI Filing Summary & Sentiment

File numbers found in text: 000-16867

Referenced dates: June 1, 2005

Date
June 21, 2005
Author
/s/ Theodore C. Miller
Form
CORRESP
Company
UTG INC (UTGN) (CIK 0000832480)

Letter

seccommentletter June 21, 2005 Mr. Jim B. Rosenberg Securities and Exchange Commission 450 fifth Street, N.W. Washington, D.C. 20549

RE: United Trust Group, Inc. Form 10-K for the fiscal year ended December 31, 2004 File No. 000-16867

Dear Mr. Rosenberg:

We have the following responses to your comments dated June 1, 2005 on our Form 10-K filing for the year ended December 31, 2004.

Item 7. Management's Discussion and Analysis of Financial Condition and Results...

Liquidity and Capital Resources

1. Please revise your discussion of cash flows, especially of your operating cash flows, to specifically address your sources and uses of cash. Please refer to Section IV.B. of Financial Reporting Release 72.

Response: As with most all insurance enterprises, the primary cash flow sources for the Company have been from premiums on life insurance products, income from investments and proceeds from the sales or maturity of investments. Cash outflows consist primarily of payment of benefits to policyholders and beneficiaries, current operating expenses and payments in connection with investments acquired. We believe theses areas to be apparent to the reader from the face of the financial statements. These significant items all appear on the face of the income statement or cash flow statement, and therefore we did not repeat them in the discussion. Given the staff's comment, we propose to expand the discussion in future filings to include a table summarizing this information or direct the reader to the detail provided in the financial statements.

2. Please provide the disclosures required by Item 303(a)(5) of Regulation S-K. In so doing, please include the expected settlement of the future policy benefits liability in the contractual obligation table. In this regard, please note that it would appear that your future policy benefits represent future legal obligations of the Company. Due to the significant nature of these liabilities to your business, we believe the inclusion of these liabilities in the contractual obligation table will provide investors increased disclosure of your liquidity. The purpose of Financial Reporting Release 67 is to obtain enhanced disclosure concerning a registrant's contractual payment obligations and the exclusion of ordinary course items would be inconsistent with the objective of the Item 303(a)(5).

Response: UTG has no debt outstanding, no capital lease obligations, no material operating lease obligations and no purchase obligations. Future policy benefits reflect liabilities such as expected death claims. In general, this balance sheet line item represents the Company's expected obligation on products that have insurance risk. Due to the nature of these liabilities, maturity is event dependent and therefore, is indeterminate. As a result, we did not interpret them to fall within the category of "other long-term liabilities" for purposes of Item 303(a)(5). However, given the staff's comment, we propose adding in future annual reports a disclosure about the Company's future policy benefits and their indeterminate maturity.

3. "Net cash provided by operating activities plus policyholder contract deposits less policyholder contract withdrawals" appears to be a non-GAAP measure, as defined by Item 10(e)(2) of Regulation S-K. Please tell us why this measure is not prohibited by Item 10(e)(1)(ii)(A) or remove the measure from your filing. If it is not prohibited and not removed, please provide the disclosures required by Item 10(e)(1)(I)(B).

Response: We do not believe the disclosure represents an impermissible non-GAAP measure. Financial Reporting Release 72 section IV B 1 states "The discussion and analysis of operating cash flows should not be limited by the manner of presentation in the statement of cash flows." The data presented is derived directly from information contained in the cash flow statement and is acknowledged in sufficient detail that the reader would be able to look at the cash flow statement - specifically, components of the operating activities and financing activities cash flows set out in the financial statements. It is presented along with disclosures about the cash flow categories, as set out in the financial statements, together with a statement about management's use of this information. Given the staff's comments, we will omit this presentation of information in future filings.

Item 8. Financial Statements and Supplementary Data

Notes to Consolidated Financial Statements

4. Under Products in Item 1. Business, we noted that the goal of your product portfolio is for it to consist of enough offerings to provide for the needs of the general public and existing policyholders. As such, please tell us how you have provided the disclosures required by paragraph 37 of SFAS 131. Otherwise, please tell us the disclosures you will provide to comply with paragraph 37.

Response: The Company offers various life insurance products to its customers. We believe these product offerings are similar and represent a single marketplace. All are to provide protection on the life of the individual insured. Each product may have slightly varied options such as face amount of policy available or premium payment options, but all remain similar in nature overall and target the same groups of clients.

1. Organization and Summary of Significant Accounting Policies

H. Reinsurance

5. Please tell us whether and to what extent liabilities related to policies assumed are more uncertain and susceptible to future changes than those you write directly due to the nature of the information (e.g. not being the direct writer) available to you at the time you record them, and tell us how you considered these uncertainties in your MD&A disclosure including critical accounting estimates.

Response: Almost all (99.8%) of the reinsurance assumed represents Universal Guaranty Life Insurance Company's (UG) percentage participation in the Servicemembers Group Life Insurance program (SGLI). This program is administered by Prudential, one of the nations largest insurance entities. SGLI provides term life insurance coverage to members of the armed forces of the United States. UG's participation in this pool is very small, approximately two tenths of one percent (.2%) of the entire pool. Prudential is a major participant in this pool as are many insurance companies, including most of the major carriers in the U.S. This arrangement has been in existence for many years as has been UG's participation in the arrangement. Management feels confident in the administration and handling of this pool arrangement by Prudential and does not believe there to be any significant uncertainties to this arrangement as compared to other insurance policies currently in force. UG received approximately $2,000 in 2004 under this arrangement.

6. In Schedule IV, we noted that the proportion of premiums on life insurance assumed to life insurance in force assumed is considerably less than the proportion for both your gross and ceded life insurance. Please clarify for us why the differences in the proportions exist and describe the types of risks you are assuming, compared with what you are writing and ceding.

Response: See explanation under question 5.

Item 9A. Controls and Procedures

7. We noted that your CEO and CFO concluded that your disclosure controls and procedures were effective in alerting them on a timely basis to material information required to be included in your periodic filings. Please revise your disclosures to clearly state whether your disclosure controls and procedures, as defined by Exchange Act Rule 13a-15, were effective, as the definition of disclosure controls and procedures would appear to encompass more than just the timely alerting of material information. Otherwise, please tell us how your disclosures comply with Item 307 of Regulation S-B.

Response: We are filing an amendment to the Form 10-K to include the following disclosure under Item 9A:

The Company carried out an evaluation, under the supervision and with the participation of its management, including its Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of its disclosure controls and procedures as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company's disclosure controls and procedures were effective.

There were no changes in the Company's internal control over financial reporting during the Company's fiscal quarter ended December 31, 2004 that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

Item 15. Exhibits and Financial Statement Schedules

Exhibit 31.1 - Certificate of Chief Executive Officer pursuant to Rule 13a-14(a)

8. Please revise this Exhibit and Exhibit 31.2 so that their language is exactly that same as the language in Item 601(b)(31) of Regulation S-K.

Response: Both Exhibit 31.1 and 31.2 have been revised to be exactly the same as the language in Item 601(b)(31) of Regulation S-K (except for certain references to internal control over financial reporting which are not yet applicable to the Company).

In addition to the above responses, the undersigned further acknowledges the following:

• The company is responsible for the adequacy and accuracy of the disclosure in the filings;

• Staff comments or changes to disclosure in response to staff comments in the filings reviewed by the staff do not foreclose the Commission from taking any action with respect to the filing; and

• The company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

As explained above, we propose addressing the staff's comments regarding disclosures made in the management's discussion and analysis in future filings of the Company, instead of an amendment to the Company's 2004 annual report. We believe the Company can appropriately address the staff's comments in this manner.

Please contact me should you need any additional information or have any further questions regarding this matter. My telephone number is (217) 241-6300.

Sincerely,
/s/ Theodore C. Miller

Show Raw Text
CORRESP
1
filename1.htm

seccommentletter

June 21, 2005

Mr. Jim B. Rosenberg
Securities and Exchange Commission
450 fifth Street, N.W.
Washington, D.C.  20549

RE:      United Trust Group, Inc.
         Form 10-K for the fiscal year ended December 31, 2004
         File No. 000-16867

Dear Mr. Rosenberg:

We have the following  responses to your comments dated June 1, 2005 on our Form
10-K filing for the year ended December 31, 2004.

Item 7.  Management's Discussion and Analysis of Financial Condition and Results...

Liquidity and Capital Resources

     1.   Please  revise  your  discussion  of cash  flows,  especially  of your
          operating cash flows, to specifically address your sources and uses of
          cash. Please refer to Section IV.B. of Financial Reporting Release 72.

     Response:  As with most all  insurance  enterprises,  the primary cash flow
     sources for the Company have been from premiums on life insurance products,
     income  from  investments  and  proceeds  from  the  sales or  maturity  of
     investments.  Cash  outflows  consist  primarily  of payment of benefits to
     policyholders and beneficiaries, current operating expenses and payments in
     connection  with  investments  acquired.  We  believe  theses  areas  to be
     apparent to the reader  from the face of the  financial  statements.  These
     significant  items all appear on the face of the income  statement  or cash
     flow  statement,  and  therefore we did not repeat them in the  discussion.
     Given the staff's  comment,  we propose to expand the  discussion in future
     filings  to  include a table  summarizing  this  information  or direct the
     reader to the detail provided in the financial statements.

     2.   Please  provide  the   disclosures   required  by  Item  303(a)(5)  of
          Regulation S-K. In so doing, please include the expected settlement of
          the future policy  benefits  liability in the  contractual  obligation
          table.  In this  regard,  please  note that it would  appear that your
          future  policy  benefits  represent  future legal  obligations  of the
          Company.  Due to the significant  nature of these  liabilities to your
          business,  we  believe  the  inclusion  of  these  liabilities  in the
          contractual   obligation  table  will  provide   investors   increased
          disclosure  of your  liquidity.  The  purpose of  Financial  Reporting
          Release 67 is to obtain enhanced disclosure  concerning a registrant's
          contractual  payment  obligations and the exclusion of ordinary course
          items would be inconsistent with the objective of the Item 303(a)(5).

     Response:  UTG has no debt outstanding,  no capital lease  obligations,  no
     material  operating lease obligations and no purchase  obligations.  Future
     policy  benefits  reflect  liabilities  such as expected  death claims.  In
     general,  this balance sheet line item  represents  the Company's  expected
     obligation on products that have insurance risk. Due to the nature of these
     liabilities,  maturity is event dependent and therefore,  is indeterminate.
     As a result,  we did not  interpret  them to fall  within the  category  of
     "other  long-term  liabilities"  for purposes of Item  303(a)(5).  However,
     given the staff's  comment,  we propose  adding in future annual  reports a
     disclosure   about  the  Company's   future   policy   benefits  and  their
     indeterminate maturity.

     3.   "Net cash provided by operating activities plus policyholder  contract
          deposits  less  policyholder  contract  withdrawals"  appears  to be a
          non-GAAP  measure,  as defined by Item  10(e)(2)  of  Regulation  S-K.
          Please  tell  us  why  this   measure  is  not   prohibited   by  Item
          10(e)(1)(ii)(A)  or remove the measure from your filing.  If it is not
          prohibited and not removed, please provide the disclosures required by
          Item 10(e)(1)(I)(B).

     Response:  We do not believe the  disclosure  represents  an  impermissible
     non-GAAP measure. Financial Reporting Release 72 section IV B 1 states "The
     discussion  and analysis of  operating  cash flows should not be limited by
     the  manner of  presentation  in the  statement  of cash  flows."  The data
     presented is derived directly from  information  contained in the cash flow
     statement and is acknowledged in sufficient detail that the reader would be
     able to look at the cash flow statement -  specifically,  components of the
     operating  activities  and financing  activities  cash flows set out in the
     financial statements. It is presented along with disclosures about the cash
     flow categories,  as set out in the financial  statements,  together with a
     statement about  management's  use of this  information.  Given the staff's
     comments, we will omit this presentation of information in future filings.

Item 8.  Financial Statements and Supplementary Data

Notes to Consolidated Financial Statements

     4.   Under  Products  in Item 1.  Business,  we noted that the goal of your
          product  portfolio is for it to consist of enough offerings to provide
          for the needs of the general  public and  existing  policyholders.  As
          such, please tell us how you have provided the disclosures required by
          paragraph 37 of SFAS 131.  Otherwise,  please tell us the  disclosures
          you will provide to comply with paragraph 37.

     Response:  The  Company  offers  various  life  insurance  products  to its
     customers.  We believe these product  offerings are similar and represent a
     single  marketplace.  All  are to  provide  protection  on the  life of the
     individual  insured.  Each product may have slightly varied options such as
     face amount of policy available or premium payment options,  but all remain
     similar in nature overall and target the same groups of clients.

1.   Organization and Summary of Significant Accounting Policies

H.   Reinsurance

     5.   Please  tell us  whether  and to what  extent  liabilities  related to
          policies  assumed are more uncertain and susceptible to future changes
          than those you write  directly  due to the  nature of the  information
          (e.g.  not being the direct  writer)  available to you at the time you
          record them, and tell us how you  considered  these  uncertainties  in
          your MD&A disclosure including critical accounting estimates.

     Response:   Almost  all  (99.8%)  of  the  reinsurance  assumed  represents
     Universal Guaranty Life Insurance  Company's (UG) percentage  participation
     in the Servicemembers  Group Life Insurance program (SGLI). This program is
     administered by Prudential,  one of the nations largest insurance entities.
     SGLI provides term life  insurance  coverage to members of the armed forces
     of the  United  States.  UG's  participation  in this  pool is very  small,
     approximately  two  tenths  of  one  percent  (.2%)  of  the  entire  pool.
     Prudential  is a major  participant  in this  pool  as are  many  insurance
     companies,   including  most  of  the  major  carriers  in  the  U.S.  This
     arrangement  has  been  in  existence  for  many  years  as has  been  UG's
     participation  in  the  arrangement.  Management  feels  confident  in  the
     administration and handling of this pool arrangement by Prudential and does
     not believe there to be any significant  uncertainties  to this arrangement
     as compared to other  insurance  policies  currently in force.  UG received
     approximately $2,000 in 2004 under this arrangement.

     6.   In  Schedule  IV, we noted that the  proportion  of  premiums  on life
          insurance  assumed to life insurance in force assumed is  considerably
          less than the proportion for both your gross and ceded life insurance.
          Please clarify for us why the differences in the proportions exist and
          describe the types of risks you are  assuming,  compared with what you
          are writing and ceding.

     Response: See explanation under question 5.

Item 9A.  Controls and Procedures

     7.   We noted that your CEO and CFO concluded that your disclosure controls
          and  procedures  were  effective in alerting them on a timely basis to
          material information required to be included in your periodic filings.
          Please  revise  your   disclosures   to  clearly  state  whether  your
          disclosure  controls and  procedures,  as defined by Exchange Act Rule
          13a-15,  were effective,  as the definition of disclosure controls and
          procedures  would  appear  to  encompass  more  than  just the  timely
          alerting of material information.  Otherwise,  please tell us how your
          disclosures comply with Item 307 of Regulation S-B.

     Response:  We are  filing  an  amendment  to the Form 10-K to  include  the
     following disclosure under Item 9A:

     The Company  carried out an evaluation,  under the supervision and with the
     participation of its management,  including its Chief Executive Officer and
     Chief Financial  Officer,  of the effectiveness of the design and operation
     of its  disclosure  controls  and  procedures  as of the end of the  period
     covered  by this  report.  Based on that  evaluation,  the Chief  Executive
     Officer and Chief Financial Officer concluded that the Company's disclosure
     controls and procedures were effective.

     There were no changes in the  Company's  internal  control  over  financial
     reporting  during the Company's fiscal quarter ended December 31, 2004 that
     have materially  affected,  or are reasonably likely to materially  affect,
     the Company's internal control over financial reporting.

Item 15.  Exhibits and Financial Statement Schedules

Exhibit 31.1 - Certificate of Chief Executive Officer pursuant to Rule 13a-14(a)

     8.   Please revise this Exhibit and Exhibit 31.2 so that their  language is
          exactly that same as the  language in Item  601(b)(31)  of  Regulation
          S-K.

     Response:  Both  Exhibit  31.1 and 31.2 have been revised to be exactly the
     same as the  language  in Item  601(b)(31)  of  Regulation  S-K (except for
     certain  references to internal control over financial  reporting which are
     not yet applicable to the Company).

In addition to the above  responses,  the undersigned  further  acknowledges the
following:

     •    The  company is  responsible  for the  adequacy  and  accuracy  of the
          disclosure in the filings;

     •    Staff  comments or changes to disclosure in response to staff comments
          in the filings  reviewed by the staff do not foreclose the  Commission
          from taking any action with respect to the filing; and

     •    The  company  may  not  assert  staff  comments  as a  defense  in any
          proceeding initiated by the Commission or any person under the federal
          securities laws of the United States.

As  explained  above,  we propose  addressing  the  staff's  comments  regarding
disclosures made in the  management's  discussion and analysis in future filings
of the Company,  instead of an amendment to the Company's 2004 annual report. We
believe  the  Company can  appropriately  address  the staff's  comments in this
manner.

Please contact me should you need any additional information or have any further
questions regarding this matter. My telephone number is (217) 241-6300.

Sincerely,

/s/ Theodore C. Miller

Theodore C. Miller
Sr. Vice President